跳至主要内容
临床试验/DRKS00032218
DRKS00032218招募中Unknown

Investigation of the Efficacy of Metacognitive Training for Patients with Long-COVID - A Randomized Controlled Trial

Klinikum Christophsbad, Akademie für Psychotherapie (C-AP), Forschungssektion für Angewandte Psychotherapie und Psychiatrie0 个研究点目标入组 40 人开始时间: 2024年5月2日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Minimum age: 18 years
  • Fluent in written and spoken German (to ensure understanding of diagnostic assessments and intervention).
  • Confirmed COVID-19 infection in the past, proven by a laboratory test (U07.1!)

排除标准

  • Acute suicidality
  • Acute danger to others
  • Acute self-harm
  • Bipolar disorders (current or past episodes)
  • Schizophrenic disorders (current or past episodes)
  • Current psychotherapy, or unwillingness to pause current psychotherapy for the duration of the study (from T1 to T3)
  • Consumption of addictive substances other than alcohol and nicotine in the past 3 months
  • Presence of a addiction disease

研究者

发起方
Klinikum Christophsbad, Akademie für Psychotherapie (C-AP), Forschungssektion für Angewandte Psychotherapie und Psychiatrie

相似试验

Investigation of the Efficacy of Metacognitive... | 临床试验